MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $203,895 | -35.1% | 4,500 | 0.0% | 0.03% | -38.9% |
| Q3 2022 | $314,000 | +4.0% | 4,500 | 0.0% | 0.05% | +10.2% |
| Q2 2022 | $302,000 | -18.4% | 4,500 | 0.0% | 0.05% | -2.0% |
| Q1 2022 | $370,000 | -43.9% | 4,500 | 0.0% | 0.05% | -39.8% |
| Q4 2021 | $660,000 | -17.1% | 4,500 | 0.0% | 0.08% | -23.1% |
| Q3 2021 | $796,000 | +9.5% | 4,500 | 0.0% | 0.11% | +11.3% |
| Q2 2021 | $727,000 | -5.7% | 4,500 | 0.0% | 0.10% | -11.8% |
| Q1 2021 | $771,000 | -22.0% | 4,500 | 0.0% | 0.11% | -27.6% |
| Q4 2020 | $988,000 | +32.3% | 4,500 | 0.0% | 0.15% | +13.4% |
| Q3 2020 | $747,000 | +45.3% | 4,500 | 0.0% | 0.13% | +38.1% |
| Q2 2020 | $514,000 | +48.6% | 4,500 | 0.0% | 0.10% | +22.8% |
| Q1 2020 | $346,000 | -40.3% | 4,500 | 0.0% | 0.08% | -19.4% |
| Q4 2019 | $580,000 | – | 4,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |